SCHEMBL6953402

SCHEMBL6953402

CCOC(=O)CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 5/20 0.60
ALDH1A1 P00352 5/20 0.60
L3MBTL1 Q9Y468 2/20 0.60
MEN1 O00255 7/20 0.58
KMT2A Q03164 7/20 0.58
POLB P06746 4/20 0.52
MAPT P10636 5/20 0.49
KDM4E B2RXH2 5/20 0.49
RAB9A P51151 2/20 0.49
NPC1 O15118 1/20 0.49
LMNA P02545 1/20 0.49
SHMT2 P34897 1/20 0.49
KAT8 Q9H7Z6 2/20 0.44
MAPK1 P28482 1/20 0.41
RECQL P46063 1/20 0.40
TDP1 Q9NUW8 3/20 0.40
APP P05067 2/20 0.40
CYP1A2 P05177 1/20 0.40
CHRM2 P08172 1/20 0.40
CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8427551 0.94 GAA (0.58) GAAALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL4664663 0.89 GAA (0.76) GAAALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL8425819 0.88 MEN1 (0.60) GAAALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL8633892 0.83 SHMT2 (0.70) GAAALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL13597563 0.83 GAA (0.56) GAAALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL8428093 0.82 GAA (0.47) GAAALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL6947831 0.81 SHMT2 (0.58) GAAALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL8425552 0.80 POLB (0.55) GAAALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL8760381 0.80 GAA (0.79) GAAALDH1A1MEN1KMT2APOLB
SCHEMBL4620529 0.80 GAA (0.55) GAAALDH1A1L3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0743304-B1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US disclosed
EP-0743304-A1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GmbH (DE) 1996-11-20 EP disclosed